Follow
Michael Dybek
Michael Dybek
Verified email at sju.edu
Title
Cited by
Cited by
Year
Pharmaceutical chemistry
A Abelian, M Dybek, J Wallach, B Gaye, A Adejare
Remington, 105-128, 2021
422021
Novel NMDA-receptor antagonists ameliorate vanadium neurotoxicity
AD Ladagu, FE Olopade, OR Folarin, TO Elufioye, JV Wallach, MB Dybek, ...
Naunyn-Schmiedeberg's Archives of Pharmacology 393, 1729-1738, 2020
112020
Syntheses and analytical characterizations of the research chemical 1‐[1‐(2‐fluorophenyl)‐2‐phenylethyl] pyrrolidine (fluorolintane) and five of its isomers
M Dybek, J Wallach, PV Kavanagh, T Colestock, N Filemban, G Dowling, ...
Drug Testing and Analysis 11 (8), 1144-1161, 2019
72019
Remington
A Abelian, M Dybek, J Wallach, B Gaye, A Adejare
Academic Press,, 2021
52021
Pharmacological characterizations of the'legal high'fluorolintane and isomers
J Wallach, T Colestock, J Agramunt, MDB Claydon, M Dybek, N Filemban, ...
European journal of pharmacology 857, 172427, 2019
52019
New cytotoxic compounds from the leaves of Caesalpinia benthamiana (Baill.) Herend. & Zarucchi (Fabaceae)
TI Famojuro, TO Elufioye, OA Olajide, M Dybek, A Adejare
Avicenna Journal of Phytomedicine 11 (1), 54, 2021
22021
Structure Activity Relationship (SAR) Studies of 1, 2-Diarylethylamines as N-Methyl-D-Aspartate Receptor Antagonists
MB Dybek
Saint Joseph's University, 2023
2023
Syntheses and evaluations of arylbicycloalkylamines as NMDAR antagonists
M Dybek, A Adejare
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 252, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–8